A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to argenx
Related studies linked through entity extraction aliases.
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokinetic Noninferiority of Empasiprubart SC Versus Intravenous (IV) in Healthy Adult Participants
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess the Safety of ARGX-124 in Healthy Volunteers
- Status
- RECRUITING
- Phase
- PHASE1
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Status
- RECRUITING
- Phase
- PHASE2
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Status
- RECRUITING
- Phase
- PHASE2
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
- Status
- RECRUITING
- Phase
- N/A
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Status
- RECRUITING
- Phase
- PHASE3
Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2